Loading…
Epigral (EPIGRAL)₹890.25−2.51%Specialty Chemicals
Epigral is compared with the 10 closest in size in Specialty Chemicals (135 companies in the industry). It has a P/E of 14.2 against a peer median of 41.9, and ROCE of 15.0% against a peer median of 14.0%, and latest-quarter sales growth of 16.2% against a peer median of 26.1%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Specialty Chemicals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Archean Chemical Industries | 5,261 | 52.7 | 7.0 | 5.4 | 0.24 | 0.6 | 1,085 | 105 | 27.5 | 6.9 | vs EPIGRAL |
| Foseco India | 4,654 | 47.9 | 17.0 | 12.6 | 0.00 | 0.4 | 641 | 75 | — | — | vs EPIGRAL |
| Prasol Chemicals | 4,576 | 54.1 | 24.1 | 20.6 | 0.25 | 0.0 | 1,231 | 83 | 35.6 | 153.8 | vs EPIGRAL |
| Laxmi Organic Industries | 4,503 | 36.1 | 5.0 | 4.1 | 0.27 | 0.2 | 2,843 | 79 | 39.6 | 223.8 | vs EPIGRAL |
| Yasho Industries | 4,124 | 47.6 | 8.9 | 5.9 | 1.27 | 0.0 | 831 | 25 | 90.0 | 581.6 | vs EPIGRAL |
| Tatva Chintan Pharma Chem | 3,904 | 61.9 | 7.0 | 5.5 | 0.21 | 0.1 | 505 | 42 | 75.1 | 109.8 | vs EPIGRAL |
| Epigral | 3,837 | 14.2 | 15.0 | 16.1 | 0.26 | 0.6 | 2,517 | 331 | 16.2 | −38.0 | — |
| Vishnu Chemicals | 3,789 | 25.3 | 16.1 | 14.4 | 0.49 | 0.1 | 1,612 | 141 | 24.7 | 25.0 | vs EPIGRAL |
| Chemplast Sanmar | 3,758 | — | 0.0 | −6.8 | 1.12 | 0.0 | 4,218 | −281 | 2.3 | — | vs EPIGRAL |
| Styrenix Performance Materials | 3,272 | 13.0 | 14.0 | 14.1 | 0.40 | 2.5 | 3,428 | 183 | 24.3 | −48.9 | vs EPIGRAL |
| Ddev Plastiks Industries | 2,599 | 12.8 | 31.0 | 21.9 | 0.06 | 0.7 | 2,944 | 203 | 3.9 | 5.8 | vs EPIGRAL |
| Peer median | 3,904 | 41.9 | 14.0 | 12.6 | 0.26 | 0.2 | 1,612 | 83 | 26.1 | 25.0 |
Listed companies closest to Epigral in Specialty Chemicals include Archean Chemical Industries, Foseco India, Prasol Chemicals, Laxmi Organic Industries, Yasho Industries, Tatva Chintan Pharma Chem, Vishnu Chemicals, Chemplast Sanmar.
Archean Chemical Industries, with a market cap of ₹5,261 Cr.
Epigral trades at a P/E of 14.2; the median of its peer set is 41.9. A P/E above or below the median is a description, not a judgement on value.
Epigral's return on capital employed is 15.0%, above the peer median of 14.0%.